🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the safety and immunogenicity of new for...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-12-09
Trial ID
NCT01248884
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of t...
Status
Recruiting
Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Start Date
2023-12-21
Trial ID
NCT06344065
Treatments Being Tested
This study evaluates the immunogenicity and safety of Infanrix hexa™ (DTPa-...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-16
Trial ID
NCT01353703
Treatments Being Tested
The purpose of this study is to evaluate safety and immunogenicity of Pedia...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00343421
Treatments Being Tested
This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT01457508
Treatments Being Tested
Currently, there are two types of vaccines available against pertussis (who...
Status
Unknown
Location
Sukuta Health Centre
Start Date
2019-01-23
Trial ID
NCT03606096
The purpose of this study is to evaluate the safety, reactogenicity, and im...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2024-01-15
Trial ID
NCT06213506
This study aims to evaluate the safety, reactogenicity and immunogenicity o...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10-01
Trial ID
NCT00390910
Treatments Being Tested
The purpose of this study is to evaluate the safety of Sabin Inactivated Po...
Status
Completed
Location
Gaoan Center for Disease Control and Prevention
Start Date
2022-06-13
Trial ID
NCT05432141
Treatments Being Tested
A prospective, randomized open-label clinical trial will be conducted from ...
Status
Completed
Location
Centers for Disease Control and Prevention
Start Date
2018-07-17
Trial ID
NCT03530124